As Pharma Ticks Higher, Managing Directors Share Picks
Despite the flurry of debate surrounding ObamaCare, which the U.S. Supreme Court is set to rule on later this week, two managing directors emphasized the new products that will be emerging from pharmaceutical companies' pipelines soon.